It is reported that in rats the repeated intermittent administration of amphetamine produces a long-lasting enhancement in medial frontal cortex dopamine utilization. This change in mesocortical dopamine activity may be involved in the behavioral sensitization produced by psychomotor stimulant drugs, and some of the cognitive abnormalities (e.g. amphetamine psychosis) associated with stimulant drug abuse in humans.
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People who are repeatedly exposed to psychomotor stimulant drugs, such as amphetamine (AMP) or cocaine, sometimes develop cognitive and behavioral abnormalities that are similar to those associated with paranoid schizophrenia 10.t~,16,24. Although this A M P psychosis dissipates upon withdrawal from the drug, former A M P addicts are hypersensitive to the psychotomimetic effects of A M P even after years of abstinence 30. This suggests that A M P produces a very long-lasting change in some neural system(s) involved in the psychotomimetic effects of stimulants.
The repeated intermittent administration of A M P to non-human animals also produces progressive and enduring changes in behavior, a phenomenon known as behavioral sensitization 12,17,~9,~2. It is thought that behavioral sensitization represents an animal model of A M P psychosis2<25,31,33, and therefore there have been many attempts to identify an enduring change in the brains of non-human animals previously exposed to AMp2, 23, 25, 33 . Most of these latter studies have concentrated on the mesostriatal dopamine (DA) system, largely because A M P causes D A release, and mesostriatal D A neurons are known to be important in mediating some of the behavioral effects of AMP. However, despite these efforts, the neural basis of behavioral sensitization is not well understood23,33.
In the experiments reported here we examined the long-term effects of repeated intermittent injections of A M P on frontal cortex D A activity for two major reasons. One, it seemed possible that a treatment that causes cognitive deficits would involve cortical dysfunction of some kind. Second, it has been suggested that behavioral sensitization is not unique to the psychopharmacology of stimulants, but can also be produced by stress 3,4,22. One well-established effect of footshock stress is a relatively selective enhancement in mesocortical D A utilization 6,1s,26,35. Therefore, we hypothesized that if A M P produces its enduring effects on brain and behavior by its action as a stressor, it may also produce an enduring enhancement in mesocortical D A utilization.
The first experiment to test this hypothesis was conducted in ovariectomized (OVX) female rats. Female rats were used because: (1) they show much more robust behavioral sensitization than males27,29; and (2) OVX females are likely to show less variation in dopaminergic activity than intact cycling females 7,s. At least 3 weeks after OVX the animals were assigned to one of 3 groups. Animals in two of these groups received 7 daily i.p. injections of either 3.0 mg/kg D-AMP sulfate or 0.9% saline. Eight days after the last injection of A M P or saline, all of these animals received an i.p. injection of 200 mg/kg of a-
